Skip to main content

Written question asked by Clive Jones (Liberal Democrat) on Wednesday, 11 June 2025, in the House of Commons. It was due for an answer on Friday, 13 June 2025. It was answered by Ashley Dalton (Labour) on Thursday, 19 June 2025 on behalf of the Department of Health and Social Care.


Urinary Tract Infections: Vaccination

Question

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 June 2025 to Question 57594 on Urinary Tract Infections: Vaccination, whether the Joint Committee on Vaccination and Immunisation (a) is reviewing and (b) plans to review available vaccines for Urinary Tract Infection for use in the UK.

Answer

The Joint Committee on Vaccination and Immunisation (JCVI) has identified vaccines to prevent recurrent urinary tract infections (UTI). These are currently in development.

During a sub-committee meeting of the JCVI held on 25 November 2024, the pipeline vaccine against recurrent UTIs, known as uromune-MV140, was presented by its manufacturer, Inmunotek. Therapeutic vaccines are considered by the National Institute for Health and Care Excellence (NICE). The committee awaits advice on whether the NICE will review this product. The minutes of the JCVI’s subcommittee meeting have been published on the JCVI website, at the following link:

https://app.box.com/s/wv2uxkv7v9bisuf8ml8mdb19iemnzmv8/file/1808036070368


Secondary information

Type
Written question
Reference
59218
Session
2024-26
Related items
Urinary Tract Infections: Vaccination
Tuesday, 10 June 2025
Written questions
House of Commons
Registered interest declared
Yes
Subjects
Vaccination Urinary tract infections
Link
View this Written question on www.parliament.uk